Welcome to our dedicated page for Regency Centers SEC filings (Ticker: REGCP), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Regency Centers's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Regency Centers's regulatory disclosures and financial reporting.
REGENCY CENTERS CORP director James H. Simmons III acquired additional common stock through equity award vesting rather than open-market trading. On May 11, 2026, he exercised and settled equity grants covering 1,807 shares of common stock, consisting of 1,736 restricted stock and 71 dividend equivalent rights under Regency’s Omnibus Incentive Plan. Following these compensation-related transactions, the filing shows he directly owns 7,978 shares of common stock.
REGENCY CENTERS CORP director James H. Simmons III acquired additional common stock through equity award vesting rather than open-market trading. On May 11, 2026, he exercised and settled equity grants covering 1,807 shares of common stock, consisting of 1,736 restricted stock and 71 dividend equivalent rights under Regency’s Omnibus Incentive Plan. Following these compensation-related transactions, the filing shows he directly owns 7,978 shares of common stock.
BLANKENSHIP C RONALD reported acquisition or exercise transactions in this Form 4 filing.
Regency Centers Corp director C. Ronald Blankenship received 453 shares of Common Stock as compensation. The shares were granted as director's fees paid in stock under Regency's Omnibus Incentive Plan rather than through an open-market purchase. Following this award, Blankenship directly holds 112,804 shares of Regency Centers Common Stock.
BLANKENSHIP C RONALD reported acquisition or exercise transactions in this Form 4 filing.
Regency Centers Corp director C. Ronald Blankenship received 453 shares of Common Stock as compensation. The shares were granted as director's fees paid in stock under Regency's Omnibus Incentive Plan rather than through an open-market purchase. Following this award, Blankenship directly holds 112,804 shares of Regency Centers Common Stock.
Regency Centers Corp director Peter Linneman reported stock-based compensation and a restricted stock conversion. On May 6, 2026, he received 336 shares of common stock as director’s fees paid in stock under Regency’s Omnibus Incentive Plan. The filing also shows the exercise of a Restricted Stock Grant covering 2,150 shares of common stock. These shares vest 100% on May 6, 2027. Following these acquisitions, Linneman directly owns 53,936 shares of Regency Centers common stock, reflecting a routine increase in his equity stake through compensation awards.
Regency Centers Corp director Peter Linneman reported stock-based compensation and a restricted stock conversion. On May 6, 2026, he received 336 shares of common stock as director’s fees paid in stock under Regency’s Omnibus Incentive Plan. The filing also shows the exercise of a Restricted Stock Grant covering 2,150 shares of common stock. These shares vest 100% on May 6, 2027. Following these acquisitions, Linneman directly owns 53,936 shares of Regency Centers common stock, reflecting a routine increase in his equity stake through compensation awards.
REGENCY CENTERS CORP director James H. Simmons III exercised a restricted stock grant for 2,150 shares of common stock. The filing classifies this as a derivative exercise/conversion with no cash price per share, indicating a compensation-related equity award rather than an open‑market trade. Following the transaction, Simmons holds 2,150 shares from this grant directly. According to the footnote, these shares vest 100% on May 6, 2027, meaning they become fully earned on that date if conditions are satisfied.
REGENCY CENTERS CORP director James H. Simmons III exercised a restricted stock grant for 2,150 shares of common stock. The filing classifies this as a derivative exercise/conversion with no cash price per share, indicating a compensation-related equity award rather than an open‑market trade. Following the transaction, Simmons holds 2,150 shares from this grant directly. According to the footnote, these shares vest 100% on May 6, 2027, meaning they become fully earned on that date if conditions are satisfied.
Regency Centers Corp director Thomas W. Furphy reported a compensation-related equity transaction. He exercised a derivative security labeled as a Restricted Stock Grant to acquire 2,150 shares of Common Stock at a price of $0.00 per share, held directly.
After this transaction, his reported direct holdings of this security total 2,150 shares. A footnote states that these shares vest 100% on May 6, 2027, indicating they are subject to a time-based vesting schedule rather than an open-market purchase or sale.
Regency Centers Corp director Thomas W. Furphy reported a compensation-related equity transaction. He exercised a derivative security labeled as a Restricted Stock Grant to acquire 2,150 shares of Common Stock at a price of $0.00 per share, held directly.
After this transaction, his reported direct holdings of this security total 2,150 shares. A footnote states that these shares vest 100% on May 6, 2027, indicating they are subject to a time-based vesting schedule rather than an open-market purchase or sale.
Regency Centers Corp director Deirdre Evens reported a compensation-related stock transaction. She exercised a derivative tied to a Restricted Stock Grant to acquire 2,340 shares of Common Stock at a price of $0.00 per share. Following this transaction, she directly holds 2,340 shares. According to a footnote, these shares vest 100% on May 6, 2027, indicating they are subject to a time-based vesting schedule rather than an open-market purchase or sale.
Regency Centers Corp director Deirdre Evens reported a compensation-related stock transaction. She exercised a derivative tied to a Restricted Stock Grant to acquire 2,340 shares of Common Stock at a price of $0.00 per share. Following this transaction, she directly holds 2,340 shares. According to a footnote, these shares vest 100% on May 6, 2027, indicating they are subject to a time-based vesting schedule rather than an open-market purchase or sale.
Regency Centers Corp director Kristin Ann Campbell reported a compensation-related stock transaction. She exercised a derivative tied to a restricted stock grant to acquire 2,150 shares of common stock, leaving her with 2,150 shares held directly after the transaction. According to the footnote, these shares vest 100% on May 6, 2027, indicating this is a time-based equity award rather than an open-market purchase or sale.
Regency Centers Corp director Kristin Ann Campbell reported a compensation-related stock transaction. She exercised a derivative tied to a restricted stock grant to acquire 2,150 shares of common stock, leaving her with 2,150 shares held directly after the transaction. According to the footnote, these shares vest 100% on May 6, 2027, indicating this is a time-based equity award rather than an open-market purchase or sale.
Regency Centers Corp director Gary E. Anderson received equity compensation in the form of restricted stock. On May 6, 2026, he acquired 2,150 shares of common stock through a restricted stock grant recorded as a derivative exercise at a price of $0.00 per share.
The award vests 100% on May 6, 2027, meaning Anderson must remain eligible through that date before the shares fully vest. After this grant, his reported direct holdings from this award total 2,150 shares, reflecting a routine, compensation-related transaction rather than an open‑market purchase or sale.
Regency Centers Corp director Gary E. Anderson received equity compensation in the form of restricted stock. On May 6, 2026, he acquired 2,150 shares of common stock through a restricted stock grant recorded as a derivative exercise at a price of $0.00 per share.
The award vests 100% on May 6, 2027, meaning Anderson must remain eligible through that date before the shares fully vest. After this grant, his reported direct holdings from this award total 2,150 shares, reflecting a routine, compensation-related transaction rather than an open‑market purchase or sale.
REGENCY CENTERS CORP director Bryce Blair reported an acquisition of equity through compensation. On May 6, 2026, he exercised a derivative award labeled as a Restricted Stock Grant to acquire 2,150 shares of underlying Common Stock at a price of $0.00 per share.
Following the transaction, Blair directly holds 2,150 shares related to this award. According to the footnote, these shares vest 100% on May 6, 2027, indicating this is a time-based equity grant rather than an open-market purchase or sale.
REGENCY CENTERS CORP director Bryce Blair reported an acquisition of equity through compensation. On May 6, 2026, he exercised a derivative award labeled as a Restricted Stock Grant to acquire 2,150 shares of underlying Common Stock at a price of $0.00 per share.
Following the transaction, Blair directly holds 2,150 shares related to this award. According to the footnote, these shares vest 100% on May 6, 2027, indicating this is a time-based equity grant rather than an open-market purchase or sale.
Regency Centers Corporation reported results from its annual shareholder meeting and declared quarterly dividends on its common and preferred stock. Shareholders elected eleven directors to serve until the 2027 annual meeting, with each nominee receiving more than 168 million votes in favor and customary broker non-votes recorded.
Shareholders also approved, on a non-binding basis, 2025 executive compensation with 164,324,175 votes for and ratified KPMG LLP as independent registered public accounting firm with 160,466,059 votes for. The board declared a quarterly cash dividend of $0.755 per share on common stock, payable July 2, 2026 to shareholders of record on June 12, 2026.
The board further declared quarterly cash dividends of $0.390625 per share on the 6.250% Series A Cumulative Redeemable Preferred Stock and $0.367200 per share on the 5.875% Series B Cumulative Redeemable Preferred Stock, each payable July 31, 2026 to holders of record on July 16, 2026.
Regency Centers Corporation reported results from its annual shareholder meeting and declared quarterly dividends on its common and preferred stock. Shareholders elected eleven directors to serve until the 2027 annual meeting, with each nominee receiving more than 168 million votes in favor and customary broker non-votes recorded.
Shareholders also approved, on a non-binding basis, 2025 executive compensation with 164,324,175 votes for and ratified KPMG LLP as independent registered public accounting firm with 160,466,059 votes for. The board declared a quarterly cash dividend of $0.755 per share on common stock, payable July 2, 2026 to shareholders of record on June 12, 2026.
The board further declared quarterly cash dividends of $0.390625 per share on the 6.250% Series A Cumulative Redeemable Preferred Stock and $0.367200 per share on the 5.875% Series B Cumulative Redeemable Preferred Stock, each payable July 31, 2026 to holders of record on July 16, 2026.